UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     
Date of Report (Date of Earliest Event Reported):   April 1, 2014

TransEnterix, Inc.
__________________________________________
(Exact name of registrant as specified in its charter)

     
Delaware 0-19437 11-2962080
_____________________
(State or other jurisdiction 		_____________
(Commission 		______________
(I.R.S. Employer
of incorporation) File Number) Identification No.)
      
635 Davis Drive, Suite 3000, Morrisville, North Carolina   27560
_________________________________
(Address of principal executive offices) 		  ___________
(Zip Code)
     
Registrant’s telephone number, including area code:   919-765-8400

Not Applicable
______________________________________________
Former name or former address, if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01 Other Events.

On April 1, 2014, TransEnterix, Inc., a Delaware corporation (the "Company") issued a press release announcing that the Company received authorization to list its common stock on the NYSE MKT, subject to the completion of a public offering of common shares and upon the Company meeting all relevant quantitative and qualitative listing criteria of the NYSE MKT, and that its Board of Directors approved a one-for-five reverse stock split of its issued and outstanding shares of common stock, which was effected on March 31, 2014. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.





Item 9.01 Financial Statements and Exhibits.

Exhibit No. Description
99.1 Press release, dated April 1, 2014





SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    TransEnterix, Inc.
          
April 1, 2014   By:   /s/ Joseph P. Slattery
       
        Name: Joseph P. Slattery
        Title: EVP and Chief Financial Officer

Exhibit Index


     
Exhibit No.   Description
 
99.1
  Press release, dated April 1, 2014
Safeguard Scientifics (QX) (USOTC:SFES)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Safeguard Scientifics (QX) Charts.
Safeguard Scientifics (QX) (USOTC:SFES)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Safeguard Scientifics (QX) Charts.